F020401 | Glycolysis

Compound Dose Time Species Model Method Action Result Positive criterion Reference
Tolcapone 3.7 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
2-Deoxy-D-glucose Positive 249
Entacapone 100 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Lonidamine Positive 249
3-Bromopyruvate Positive 249
Imatinib Positive 249
Oxythiamine Positive 249
Nilutamide 79 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Flutamide > 100 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Chlorpromazine > 300 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Diflunisal 30 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Benoxaprofen > 100 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Troglitazone > 100 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Ciglitazone > 100 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Troglitazone 10 μM 2 minutes feline cardiomyocytes Measurement of ECAR increase Positive EC50 7
Ciglitazone 10 μM 2 minutes feline cardiomyocytes Measurement of ECAR increase Positive EC50 7
Rosiglitazone > 100 μM 2 minutes feline cardiomyocytes Measurement of ECAR increase Positive EC50 7
Trimetazidine increase Positive 17
ranolazine increase Positive 17
Pioglitazone Positive 21
2,4-dinitrophenol increase Positive 24
2-Deoxy-D-glucose human SkBr3 breast cancer cells MTT assay decrease Positive 25
buformin 25 μM 24 hours human HepG2 cells Measurement of ECAR increase Positive p < 0.001 15
Phenformin 25 μM 24 hours human HepG2 cells Measurement of ECAR increase Positive p < 0.001 15
Oligomycin 1.1±0.23 μM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Metformin 5 mM 24 hours mouse NMuMG Meassurement of glucose concentration increase Positive p < 0.05 172
Clotrimazole decrease Positive 35
Metformin 5 mM 24 hours mouse NT2196 Meassurement of glucose concentration increase Positive p < 0.05 172
Metformin 5 mM 24 hours human MCF10A Meassurement of glucose concentration increase Positive p < 0.05 172
Metformin 5 mM 24 hours human MCF7 Meassurement of glucose concentration increase Positive p < 0.05 172
Metformin 5 mM 24 hours mouse NT2196 Meassurement of lactate concentration increase Positive p < 0.05 172
Metformin 5 mM 24 hours human MCF10A Meassurement of lactate concentration increase Positive p < 0.05 172
Metformin 5 mM 48 hours mouse NMuMG Meassurement of glucose concentration increase Positive p < 0.05 172
Metformin 5 mM 48 hours mouse NT2196 Meassurement of glucose concentration increase Positive p < 0.05 172
Metformin 5 mM 48 hours human MCF10A Meassurement of glucose concentration increase Positive p < 0.05 172
Metformin 5 mM 48 hours human MCF7 Meassurement of glucose concentration increase Positive p < 0.05 172
Metformin 5 mM 24 hours human MCF7 Meassurement of lactate concentration increase Positive p < 0.05 172
Metformin 5 mM 48 hours mouse NMuMG Meassurement of lactate concentration increase Positive p < 0.05 172
Metformin 5 mM 48 hours mouse NT2196 Meassurement of lactate concentration increase Positive p < 0.05 172
Metformin 5 mM 48 hours human MCF10A Meassurement of lactate concentration increase Positive p < 0.05 172
Metformin 5 mM 48 hours human MCF7 Meassurement of lactate concentration increase Positive p < 0.05 172
Rotenone 371±58 nM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
Antimycin A 100±20 nM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
iodoacetate inhibition Positive 278
Dichloroacetate inhibition Positive 278
FCCP 141±20 nM 2 minutes human HepG2 Measurement of ECAR increase Positive EC50 7
2-Deoxy-D-glucose 150 mM 2 minutes human HepG2 Measurement of ECAR decrease Positive EC50 7
2-Deoxy-D-glucose decrease Positive 35